Edoxaban 15 mg, 30 mg, 60 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 15 mg, 30 mg, 60 mg
Reference Brands: Savaysa (USA), Lixiana (EU)
Category: Heart Disorder
Edoxaban is a Heart Disorder product available as Tablets in strengths 15 mg, 30 mg, 60 mg. It corresponds to the reference brands Savaysa (USA), Lixiana (EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Edoxaban is an oral anticoagulant medication and a selective direct factor Xa inhibitor used to prevent and treat thromboembolic disorders. It works by inhibiting factor Xa, a key enzyme in the coagulation cascade, thereby reducing thrombin generation and preventing the formation of blood clots. Edoxaban is administered orally and is well-established for long-term anticoagulation therapy.
In the United States, edoxaban is approved for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) following an initial 5 to 10 days of therapy with a parenteral anticoagulant. It is also indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
In the European Union, edoxaban is indicated for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation who have one or more risk factors, including previous stroke, hypertension, diabetes mellitus, congestive heart failure, or age 75 years or older. Additionally, it is used for the treatment of DVT and PE and for the prevention of their recurrence.
Edoxaban — third party manufacturing & bulk supply
Edoxaban 15 mg, 30 mg, 60 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Edoxaban listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Edoxaban →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Edoxaban is used to prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation and to treat and prevent recurrence of deep vein thrombosis and pulmonary embolism after initial injectable anticoagulant therapy.
Edoxaban is made from the active pharmaceutical ingredient edoxaban tosylate monohydrate, a chemically synthesized direct factor Xa inhibitor.
The trade names of edoxaban are Savaysa in the USA and Lixiana in the EU and UK.
Edoxaban was developed and is marketed globally by Daiichi Sankyo.
The complete generic name is edoxaban tosylate monohydrate.
The brand names are Savaysa and Lixiana.
Edoxaban finished dosage forms and active pharmaceutical ingredient are manufactured at Daiichi Sankyo–approved facilities across Japan, Europe, and other regulated manufacturing locations, depending on the market.
Related Products
Trandolapril
Strength:
0.5 mg, 1 mg, 2 mg
Form: Tablets
Reference Brands: Mavik (USA), Gopten (EU)
View Details
Tirofiban Hydrochloride
Strength:
2.5 mg/mL
Form: Injection
Reference Brands: Aggrastat (USA)
View Details
Selexipag
Strength:
200 mcg, 400 mcg, 600 mcg, 800 mcg, 1000 mcg, 1200 mcg, 1400 mcg, 1600 mcg
Form: Tablets / Injection
Reference Brands: Uptravi (USA/EU)
View Details
Quick Response Guaranteed | Verified Suppliers
